Fluorescence imaging in the second near-infrared window
(NIR-II,
1000–1700 nm) using small-molecule dyes has high potential
for clinical use. However, many NIR-II dyes suffer from the emission
quenching effect and extremely low quantum yields (QYs) in the practical
usage forms. The AIE strategy has been successfully utilized to develop
NIR-II dyes with donor–acceptor (D–A) structures with
acceptable QYs in the aggregate state, but there is still large room
for QY improvement. Here, we rationally designed a NIR-II emissive
dye named TPE-BBT and its derivative (TPEO-BBT) by changing the electron-donating
triphenylamine unit to tetraphenylethylene (TPE). Their nanoparticles
exhibited ultrahigh relative QYs of 31.5% and 23.9% in water, respectively.
By using an integrating sphere, the absolute QY of TPE-BBT nanoparticles
was measured to be 1.8% in water. Its crystals showed an absolute
QY of 10.4%, which is the highest value among organic small molecules
reported so far. The optimized D–A interaction and the higher
rigidity of TPE-BBT in the aggregate state are believed to be the
two key factors for its ultrahigh QY. Finally, we utilized TPE-BBT
for NIR-II photoluminescence (PL) and chemiluminescence (CL) bioimaging
through successive CL resonance energy transfer and Förster
resonance energy transfer processes. The ultrahigh QY of TPE-BBT realized
an excellent PL imaging quality in mouse blood vessels and an excellent
CL imaging quality in the local arthrosis inflammation in mice with
a high signal-to-background ratio of 130. Thus, the design strategy
presented here brings new possibilities for the development of bright
NIR-II dyes and NIR-II bioimaging technologies.